Explore factors impacting RA and axSpA management, such as radiographic progression, and sex and gender differences.
Professor Brian Kirby is Consultant Dermatologist at St Vincent’s University Hospital, Dublin, Ireland, and Full Clinical Professor at University College Dublin, Ireland.
Professor Kirby’s clinical and research interests include psoriasis and hidradenitis suppurativa. He is co-Chair of the Dublin Hidradenitis Suppurativa Research Group and a Principal Investigator at the Charles Institute of Dermatology at University College Dublin.
Professor Kirby is also a former member of the steering committee of British Association of Dermatologists Biologics and Immunomodulatory Register (BADBIR), a member of the International Psoriasis Council (IPC), a member of the scientific committee of the European Hidradenitis Suppurativa Foundation (EHSF) and Chairperson of the Clinical Advisory Group of Dermatology at the Royal College of Physicians of Ireland.
He has authored or co-authored more than 250 publications, the majority of which are on psoriasis and hidradenitis suppurativa. Additionally, he is Associate Editor of the British Journal of Dermatology and Dermatology.
Explore factors impacting RA and axSpA management, such as radiographic progression, and sex and gender differences.
Integrating holistic care through guideline recommendations with patient-reported outcomes and shared decision-making
Personalised HS care: Addressing the multi-faceted burden of HS with a case study example
The role of combined medical/surgical and medical-only treatments, including the optimal time for intervention
Key guideline updates including management algorithms for inflammatory and non-inflammatory HS phenotypes
Prof. Prignano and Prof. Liakou discuss patient-reported outcomes, shared decision-making and multidisciplinary HS care